Industrial lead poisoning is becoming an uncommon event in this country and instances of lead encephalopathy are now very rare (Hunter, 1957) . Many physicians therefore have scanty experience in diagnosing and investigating such cases, which tend to gravitate more and more to centres specializing in industrial diseases. They may not be familiar with the degree of exposure liable to lead to a dangerous level of lead absorption and may have difficulty in interpreting tests which suggest that absorption has occurred. This case is reported not in the hope that it will add anything of value to the literature of lead poisoning, but because it contains certain errors and misapprehensions which it is salutary to put on record. A mistake in diagnosis was made, and it may be of interest to recount the events as they occurred and then review them in the light of the more experienced advice later received.
Case History A 63-year-old bullion refiner was admitted to hospital on January 1, 1960. He had been in good health up to the night of his admission and had experienced no metallic taste in his mouth, no constipation or colic, and no weakness of the limbs; his wife had observed nothing abnormal in his mental state. On December 31, 1959, at The employees' urine is tested at intervals for porphyrins, and on looking up the patient's record it was found that the tests had been positive for some time past. His history of exposure to lead and the coarse stippling of his red cells suggested that his symptoms were due to lead poisoning and that we were dealing with a case of lead encephalopathy. Owing to the three days' delay in diagnosis and the recurrence of fits it was decided to start treatment without undertaking a preliminary control estimation of urinary lead excretion and without pursuing further investigations such as cerebral angiography. On January 4, therefore, an intravenous infusion of 1 g. ethylenediamine tetra-acetate (EDTA, disodium calcium versenate) was administered in 500 ml. of dextrose solution. A 24-hour urine collection started synchronously with the infusion contained a total of 3-78 mg. of lead in 3,200 ml. of urine. The amount of lead in the blood 18 hours after the infusion was 190 mg./100 ml. The ensuing 24-hour excretion of lead (when no EDTA was given) was 0-38 mg. On January 7 a further gramme of EDTA was infused, and three more doses of 2 g. followed in the next four days. The urinary lead outputs on January 7 and 8 were 2-75 mg. and 2-88 mg. respectively. A further course of EDTA totalling 9 g. was given in five daily infusions from January 18 to 23, but lead excretion was not measured. The patient was discharged in apparent good health 23 days after admission.
When readmitted on February 18 for further excretion studies his resting 24-hour urinary lead output was 0-036 mg.; three more daily infusions of EDTA were given, which on the first two days resulted in a rise of lead excretion to 2-22 mg. and 1 45 mg. The results of the various estimations are set out in Table 1 .
We assumed at this point that the tissue lead concentration had been reduced to a safe level and no further treatment with EDTA was given. The patient's last fit had occurred on January 6, a week after the onset of symptoms, and his mental state had become normal the next day. He appeared perfectly well and was already back at work where his employment had been changed to avoid any further exposure to lead.
Early in April a message was received from his factory indicating that all was not well. He had been complaining of headache, had unaccountably put on over a stone in weight, and his workmates had noticed that he had lost his usual cheerfulness and was becoming slow and unreliable. Indeed his behaviour during the preceding few days had been so unlike him that he was considered unfit for work. He was readmitted on April 16.
It did not take long to make a diagnosis: reinvestigation showed that he was suffering from a cerebral tumour. The personality change was obvious; he was rational and orientated but ponderous and apathetic. Hle had a partial left facial palsy and hemiparesis. His C.S.F. now contained 140 mg. ofprotein at a pressure of250 mm.; the E.E.G. had become abnormal and indicated a space-occupying lesion in the right fronto-temporal area. Finally carotid angiography (not carried out on his original admission) revealed pathological vessels in the right frontal region with displacement of the right anterior cerebral artery to the left.
He declined rapidly and died four weeks after admission (five months after the convulsion which was his first symptom). At necropsy a large irregular primary tumour with a necrotic centre was found in the right frontal lobe, extending backwards into the parietal lobe. There was no other macroscopic abnormality in the brain and other organs were normal. Histologically the tumour was a fibrillary astrocytoma. Routine preparations from the rest of the brain showed no evidence of nerve cell damage. Microscopy of the kidneys, which to the naked eye were normal, revealed some tubular damage, with variability of the nuclei of the epithelial cells, some cytoplasmic degeneration, and an occasional mitotic figure indicative of regeneration. The damage thus displayed was by no means specific but could be attributed to lead poisoning. The bone structure of femur and vertebrae was normal. Estimations of the lead content of various tissues are given in Table 2 . Cortex.2-9 Heart.. 04 
Discussion
The patient was at first notified to the Inspector of Factories as a case of industrial lead poisoning. The most significant fact in his history was the recent shovelling of litharge. This is well known among lead workers to be a dangerous substance, and the Martindale mask which he was wearing could be considered inadequate protection for the task. The sudden increase in absorbed lead resulting from these three days' unduly heavy exposure was presumed to be the final insult superimposed on a background of slow chronic absorption. The work was heavier than he was accustomed to, and the increased pulmonary ventilation involved was well calculated to give ingress to a fine dusty form of a soluble lead oxide. He was in addition a heavy smoker who rolled his cigarettes; inhalation of lead transferred from his fingers to the tobacco was another possible source of undue absorption. He was furthermore suffering from a cold at the time, and intercurrent infections are recognized as enhancing the toxic effects of lead. That his body lead content was already raised was indicated by the positive urinary porphyrin tests recorded in the factory. The high output of lead in the urine in response to EDTA (maximum 3 78 mg./24 hrs; normal 022-0-65 mg.) again suggested lead poisoning as a possible diagnosis. Still more support was lent by his immediate improvement after treatment with EDTA, as judged by the disappearance of mental confusion and the cessation of fits.
Despite its rarity in adults lead encephalopathy remains a condition to bear in mind when neurological symptoms develop in a person known to have been exposed to lead. Clinically it may present in a wide variety of ways. Danaraj (1956) , for example, reported four cases presenting initially as encephalitis, dementia paralytica (GPI), coma, and an obscure neurological disorder. Three of of these were adults and one a boy of 11; all of them had a raised C.S.F. protein, three had an excess of lymphccytes in the C.S.F. and three had a raised C.S.F. pressure. Akelaitis (1941) emphasized that the clinical picture was that of any severe intoxication of the brain, with its resulting delirium or convulsions. The predominant pathological change was oedema of the brain, probably resulting from vascular damage; exudate was seen in the perivascular spaces, the meninges were oedematous and thickened, and proliferative changes were found in the endothelial cells of the small blood vessels (Akelaitis, 1941; Blackman, 1937) .
There have been many accounts of the use of EDTA in lead poisoning since Bessman, Ried, and Rubin (1952) first employed it successfully on a 3-year-old boy with lead encephalopathy. Treatment in the present case was carried out on the lines indicated by Leckie and Tompsett (1958) who undertook investigations on eight wire mill workers, seven of whom had been exposed to lead. They found that increasing the dose of EDTA above 2 g. did not significantly raise the urinary lead excretion, and that the duration of the infusion was of importance in achieving a good output. They suggested an infusion period of six hours, or continuous slow infusion over 48 hours in severe cases. Excessive absorption of lead was indicated by a 24-hour lead output of more than 1-5 mg. in response to 2 g. of EDTA; in control subjects the excretion lay between 0-22 and 0 65 mg. (compare 3-78 mg./ 24 hours in the present patient). A fall in excretion below 1-5 mg. in the second 24 hours of any course of infusions suggested that the available lead stores were becoming depleted.
The lead content of the patient's bones was at the upper limit of the range found in normal subjects without undue exposure to lead, and probably well beyond it. Estimates for long bones vary from less than 3 8 ,ug. per gramme wet tissue to 108 ,tg. (Cumings, 1959 
